Pre-diagnostic plasma carotenoids, tocopherols and retinol levels, and risk of amyotrophic lateral sclerosis

Loading...
Thumbnail Image
Date
2026-05-04
Authors
O'Reilly, Éilis J.
Bjornevik, Kjetil
Furtado, Jeremy D.
Patel, Alpa V.
Wang, Ying
Kolonel, Laurence N.
Le Marchand, Loïc
Ascherio, Alberto
Journal Title
Journal ISSN
Volume Title
Publisher
Published Version
Research Projects
Organizational Units
Journal Issue
Abstract
Objective: Our goal was to examine whether pre-diagnostic plasma carotenoids and tocopherols are associated with amyotrophic lateral sclerosis (ALS). Methods: A nested case–control study within 4 United States cohorts, where 154 participants with pre-diagnostic blood-draw, were diagnosed during follow-up with amyotrophic lateral sclerosis (ALS). Controls were randomly selected from participants alive on the date a case was diagnosed, matched 2:1 by cohort, sex, age, race/ethnicity, fasting-status, time of blood-draw. Carotenoid and tocopherol levels were quantified by high-performance liquid-chromatography with diode array-detector. ALS incidence or death rate ratios (RR) were estimated using conditional logistic regression adjusting for body mass index, smoking status, physical activity, cholesterol, and urate levels. Results: The association between beta-carotene and ALS varied by sex (p-for-interaction = 0.007). After matched- and multivariable-adjustment, women with higher cis-, trans- and total beta-carotene had lower incidence of ALS (RR for 1-standard deviation [SD] increase in total beta-carotene: 0.68; 95% CI: 0.48–0.98; p = 0.038), whereas a positive association was seen in men (1-SD increase: RR = 1.44; 95% CI: 1.03–2.01; p = 0.033). However, after further adjustment for other correlated carotenoids, the association in men was attenuated, whereas it remained significant in women. Women with higher beta-cryptoxanthin, but not men, had a lower risk of ALS (1-SD increase: RR = 0.67; 95% CI: 0.48–0.94; p = 0.02; p-for-interaction = 0.12). Alpha-carotene, lutein-zeaxanthin, lycopene, retinol, and tocopherols were not associated with ALS, except for a borderline inverse association of gamma-tocopherol in men (RR = 0.74; 95% CI: 0.54–1.01; p = 0.059). Interpretation: Higher pre-diagnostic plasma levels of beta-carotene and beta-cryptoxanthin in women and gamma-tocopherol in men were suggestively associated with lower ALS risk. Other carotenoids or tocopherols were not clearly associated with ALS. ANN NEUROL 2026.
Description
© 2026 The Author(s). Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Keywords
Pre-diagnostic plasma carotenoids , [PublicHealth] , and tocoAmyotrophic lateral sclerosis (ALS)
Citation
O'Reilly, É J, Bjornevik, K, Furtado, J D, Patel, A V, Wang, Y, Kolonel, L N, Le Marchand, L & Ascherio, A 2026, 'Pre-diagnostic plasma carotenoids, tocopherols and retinol levels, and risk of amyotrophic lateral sclerosis', Annals of Neurology, vol. 100, no. 2, pp. 1-10. https://doi.org/10.1002/ana.78240
Link to publisher’s version
Copyright
cc_by_nc_nd